Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,630 | 54 | 76.0% |
| Food and Beverage | $10,949 | 326 | 12.3% |
| Travel and Lodging | $7,297 | 45 | 8.2% |
| Consulting Fee | $3,000 | 1 | 3.4% |
| Education | $97.49 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $34,495 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $33,894 | 114 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $9,006 | 26 | $0 (2021) |
| Allergan, Inc. | $6,434 | 44 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $1,652 | 44 | $0 (2024) |
| Lundbeck LLC | $1,032 | 39 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $785.56 | 41 | $0 (2022) |
| Alkermes, Inc. | $776.22 | 26 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $256.71 | 3 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $129.26 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.08 | 10 | Lundbeck LLC ($177.88) |
| 2023 | $495.59 | 14 | Lundbeck LLC ($204.65) |
| 2022 | $11,247 | 41 | Supernus Pharmaceuticals, Inc. ($9,602) |
| 2021 | $26,001 | 103 | Supernus Pharmaceuticals, Inc. ($24,834) |
| 2020 | $5,897 | 49 | Janssen Pharmaceuticals, Inc ($5,019) |
| 2019 | $11,942 | 50 | Janssen Pharmaceuticals, Inc ($10,820) |
| 2018 | $15,162 | 62 | Allergan Inc. ($5,688) |
| 2017 | $17,893 | 102 | Janssen Pharmaceuticals, Inc ($12,188) |
All Payment Transactions
431 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.76 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.09 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $93.87 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: PSYCHIATRY | ||||||
| 02/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $91.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $99.38 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $34.53 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/29/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.57 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: BH | ||||||
| 07/06/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: PSYCHIATRY | ||||||
| 04/07/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: PSYCHOLOGY | ||||||
| 03/23/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $34.24 | General |
| Category: PSYCHIATRY | ||||||
| 03/16/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/30/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2023 | Sumitomo Pharma America, Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: CNS | ||||||
| 12/20/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.85 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 27 | $2,950 | $1,457 |
| 2021 | 4 | 149 | 275 | $28,875 | $15,377 |
| 2020 | 5 | 224 | 450 | $49,118 | $25,988 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 27 | $2,950 | $1,457 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 195 | $19,019 | $10,121 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 22 | $3,222 | $2,007 | 62.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 30 | $3,330 | $1,681 | 50.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 28 | $3,304 | $1,568 | 47.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 114 | 315 | $28,854 | $14,969 | 51.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 37 | $7,659 | $4,041 | 52.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 22 | 27 | $4,833 | $3,061 | 63.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 38 | 41 | $4,592 | $2,315 | 50.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 30 | $3,180 | $1,603 | 50.4% |
About Dr. Kaushik Raval, M.D
Dr. Kaushik Raval, M.D is a Psychiatry healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801995576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kaushik Raval, M.D has received a total of $88,974 in payments from pharmaceutical and medical device companies, with $337.08 received in 2024. These payments were reported across 431 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,630).
As a Medicare-enrolled provider, Raval has provided services to 385 Medicare beneficiaries, totaling 752 services with total Medicare billing of $42,823. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Saginaw, MI
- Active Since 09/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801995576
Products in Payments
- QELBREE (Drug) $31,960
- INVEGA SUSTENNA (Drug) $20,484
- INVEGA TRINZA (Drug) $13,092
- AUSTEDO (Drug) $8,443
- VRAYLAR (Drug) $6,250
- REXULTI (Drug) $2,145
- LATUDA (Drug) $799.54
- SD809-TD (Drug) $562.95
- ARISTADA (Drug) $532.61
- ABILIFY MAINTENA (Drug) $526.08
- SPRAVATO (Drug) $374.35
- INGREZZA (Drug) $256.71
- Aristada 441 mg (Drug) $213.77
- VIIBRYD (Drug) $200.00
- SUNOSI (Drug) $129.26
- CAPLYTA (Drug) $82.36
- NUEDEXTA (Drug) $78.99
- NUPLAZID (Drug) $68.43
- Qelbree (Drug) $40.82
- Auvelity (Drug) $39.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saginaw
Dr. Ali Ibrahim, M.d, M.D
Psychiatry — Payments: $5,345
Mr. Nicholas Lazurka, (Pa-C), (PA-C)
Psychiatry — Payments: $4,816
Ryan Cox, M.d, M.D
Psychiatry — Payments: $4,418
Mrs. Hema Talasila, M.d, M.D
Psychiatry — Payments: $4,351
Dr. Chalichama Rao, M.d, M.D
Psychiatry — Payments: $2,053
Samantha Grosteffon
Psychiatry — Payments: $943.34